These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 22045023)

  • 1. TAZ antagonizes the WWP1-mediated KLF5 degradation and promotes breast cell proliferation and tumorigenesis.
    Zhao D; Zhi X; Zhou Z; Chen C
    Carcinogenesis; 2012 Jan; 33(1):59-67. PubMed ID: 22045023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. YAP promotes breast cell proliferation and survival partially through stabilizing the KLF5 transcription factor.
    Zhi X; Zhao D; Zhou Z; Liu R; Chen C
    Am J Pathol; 2012 Jun; 180(6):2452-61. PubMed ID: 22632819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Fbw7 tumor suppressor targets KLF5 for ubiquitin-mediated degradation and suppresses breast cell proliferation.
    Zhao D; Zheng HQ; Zhou Z; Chen C
    Cancer Res; 2010 Jun; 70(11):4728-38. PubMed ID: 20484041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Kruppel-like factor 5 is a target of the E3 ubiquitin ligase WWP1 for proteolysis in epithelial cells.
    Chen C; Sun X; Guo P; Dong XY; Sethi P; Cheng X; Zhou J; Ling J; Simons JW; Lingrel JB; Dong JT
    J Biol Chem; 2005 Dec; 280(50):41553-61. PubMed ID: 16223724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BAP1 antagonizes WWP1-mediated transcription factor KLF5 ubiquitination and inhibits autophagy to promote melanoma progression.
    Jia X; Chen H; Ren Y; Dejizhuoga ; Gesangyuzhen ; Gao N; Feng H; Huang W; Liao Y; Yu H
    Exp Cell Res; 2021 May; 402(1):112506. PubMed ID: 33516665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Fbw7/human CDC4 tumor suppressor targets proproliferative factor KLF5 for ubiquitination and degradation through multiple phosphodegron motifs.
    Liu N; Li H; Li S; Shen M; Xiao N; Chen Y; Wang Y; Wang W; Wang R; Wang Q; Sun J; Wang P
    J Biol Chem; 2010 Jun; 285(24):18858-67. PubMed ID: 20388706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteasomal degradation of the KLF5 transcription factor through a ubiquitin-independent pathway.
    Chen C; Zhou Z; Guo P; Dong JT
    FEBS Lett; 2007 Mar; 581(6):1124-30. PubMed ID: 17320083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Krüppel-like factor 5 promotes breast cell proliferation partially through upregulating the transcription of fibroblast growth factor binding protein 1.
    Zheng HQ; Zhou Z; Huang J; Chaudhury L; Dong JT; Chen C
    Oncogene; 2009 Oct; 28(42):3702-13. PubMed ID: 19668233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ataxin-3 like (ATXN3L), a member of the Josephin family of deubiquitinating enzymes, promotes breast cancer proliferation by deubiquitinating Krüppel-like factor 5 (KLF5).
    Ge F; Chen W; Qin J; Zhou Z; Liu R; Liu L; Tan J; Zou T; Li H; Ren G; Chen C
    Oncotarget; 2015 Aug; 6(25):21369-78. PubMed ID: 26079537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WW domain-containing E3 ubiquitin protein ligase 1 targets p63 transcription factor for ubiquitin-mediated proteasomal degradation and regulates apoptosis.
    Li Y; Zhou Z; Chen C
    Cell Death Differ; 2008 Dec; 15(12):1941-51. PubMed ID: 18806757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WW domain containing E3 ubiquitin protein ligase 1 targets the full-length ErbB4 for ubiquitin-mediated degradation in breast cancer.
    Li Y; Zhou Z; Alimandi M; Chen C
    Oncogene; 2009 Aug; 28(33):2948-58. PubMed ID: 19561640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WWP1 E3 ligase targets LATS1 for ubiquitin-mediated degradation in breast cancer cells.
    Yeung B; Ho KC; Yang X
    PLoS One; 2013; 8(4):e61027. PubMed ID: 23573293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The E3 ubiquitin ligase SMAD ubiquitination regulatory factor 2 negatively regulates Krüppel-like factor 5 protein.
    Du JX; Hagos EG; Nandan MO; Bialkowska AB; Yu B; Yang VW
    J Biol Chem; 2011 Nov; 286(46):40354-64. PubMed ID: 21953463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The WW domain containing E3 ubiquitin protein ligase 1 upregulates ErbB2 and EGFR through RING finger protein 11.
    Chen C; Zhou Z; Liu R; Li Y; Azmi PB; Seth AK
    Oncogene; 2008 Nov; 27(54):6845-55. PubMed ID: 18724389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The nonreceptor tyrosine kinase c-Src attenuates SCF(β-TrCP) E3-ligase activity abrogating Taz proteasomal degradation.
    Shanzer M; Adler J; Ricardo-Lax I; Reuven N; Shaul Y
    Proc Natl Acad Sci U S A; 2017 Feb; 114(7):1678-1683. PubMed ID: 28154141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oestrogen causes degradation of KLF5 by inducing the E3 ubiquitin ligase EFP in ER-positive breast cancer cells.
    Zhao KW; Sikriwal D; Dong X; Guo P; Sun X; Dong JT
    Biochem J; 2011 Jul; 437(2):323-33. PubMed ID: 21542805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negative regulation of transforming growth factor-beta (TGF-beta) signaling by WW domain-containing protein 1 (WWP1).
    Komuro A; Imamura T; Saitoh M; Yoshida Y; Yamori T; Miyazono K; Miyazawa K
    Oncogene; 2004 Sep; 23(41):6914-23. PubMed ID: 15221015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of Krüpple-like factor 5 by targeted protein degradation.
    Chen C
    Methods Mol Biol; 2010; 647():267-77. PubMed ID: 20694673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen regulates tumor growth through a nonclassical pathway that includes the transcription factors ERβ and KLF5.
    Nakajima Y; Akaogi K; Suzuki T; Osakabe A; Yamaguchi C; Sunahara N; Ishida J; Kako K; Ogawa S; Fujimura T; Homma Y; Fukamizu A; Murayama A; Kimura K; Inoue S; Yanagisawa J
    Sci Signal; 2011 Apr; 4(168):ra22. PubMed ID: 21487105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FBXO32 suppresses breast cancer tumorigenesis through targeting KLF4 to proteasomal degradation.
    Zhou H; Liu Y; Zhu R; Ding F; Wan Y; Li Y; Liu Z
    Oncogene; 2017 Jun; 36(23):3312-3321. PubMed ID: 28068319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.